I agree that this site is using cookies. You can find further informations here.
X
Marion Anliker‐Ort
14  results:
Search for persons X
?
1

Transfer of the Dual Orexin Receptor Antagonist Daridorexan..:

Kaufmann, Priska ; Muehlan, Clemens ; Anliker‐Ort, Marion...
The Journal of Clinical Pharmacology.  , 2024
Link: https://doi.org/10.1002/..
 
?
2

Pharmacokinetics‐Based Pediatric Dose Evaluation and Optimi..:

Anliker‐Ort, Marion ; Rodieux, Frédérique ; Ziesenitz, Victoria C....
The Journal of Clinical Pharmacology.  64 (2024)  7 - p. 810-819 , 2024
Link: https://doi.org/10.1002/..
 
?
3

Evaluation of the cytochrome P450 2C19 and 3A4 inhibition p..:

Anliker‐Ort, Marion ; Dingemanse, Jasper ; Delahaye, Stephane...
Clinical and Translational Science.  16 (2023)  7 - p. 1220-1231 , 2023
Link: https://doi.org/10.1111/..
 
?
4

Modeling time‐delayed concentration‐QT effects with ACT‐101..:

Anliker‐Ort, Marion ; Hsin, Chih‐hsuan ; Krause, Andreas...
Pharmacology Research & Perspectives.  11 (2023)  4 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
5

Multiple‐ascending doses of ACT‐1014‐6470, an oral compleme..:

Anliker‐Ort, Marion ; Dingemanse, Jasper ; Farine, Hervé...
British Journal of Clinical Pharmacology.  89 (2022)  1 - p. 380-389 , 2022
Link: https://doi.org/10.1111/..
 
?
6

First‐in‐human study with ACT‐539313, a novel selective ore..:

Kaufmann, Priska ; Anliker‐Ort, Marion ; Golor, Georg..
British Journal of Clinical Pharmacology.  86 (2020)  7 - p. 1377-1386 , 2020
Link: https://doi.org/10.1111/..
 
?
7

0100 Excretion of the Dual Orexin Receptor Antagonist Darid..:

Kaufmann, Priska ; Anliker-Ort, Marion ; Siebers, Nicholas..
SLEEP.  47 (2024)  Supplement_1 - p. A44-A44 , 2024
Link: https://doi.org/10.1093/..
 
?
8

Effect of Daridorexant on the Pharmacokinetics of P-Glycopr..:

Anliker-Ort, Marion ; Dingemanse, Jasper ; Janů, Luboš.
Clinical Drug Investigation.  43 (2023)  11 - p. 827-837 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Evaluation of the cytochrome P450 2C19 and 3A4 inhibition p..:

Marion Anliker‐Ort ; Jasper Dingemanse ; Stephane Delahaye...
https://doi.org/10.1111/cts.13525.  , 2023
Link: https://doi.org/10.1111/..
 
?
10

Modeling time‐delayed concentration‐QT effects with ACT‐101..:

Marion Anliker‐Ort ; Chih‐hsuan Hsin ; Andreas Krause...
https://doi.org/10.1002/prp2.1112.  , 2023
Link: https://doi.org/10.1002/..
 
?
11

Treatment of Rare Inflammatory Kidney Diseases: Drugs Targe..:

Anliker-Ort, Marion ; Dingemanse, Jasper ; van den Anker, John.
Frontiers in Immunology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
12

Treatment of Rare Inflammatory Kidney Diseases: Drugs Targe..:

Marion Anliker-Ort ; Jasper Dingemanse ; John van den Anker.
https://www.frontiersin.org/articles/10.3389/fimmu.2020.599417/full.  , 2020
Link: https://doi.org/10.3389/..
 
?
13

Modeling time‐delayed concentration‐QT effects with ACT‐101..:

Anliker‐Ort, Marion ; Hsin, Chih‐hsuan ; Krause, Andreas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357345/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Evaluation of the cytochrome P450 2C19 and 3A4 inhibition p..:

Anliker‐Ort, Marion ; Dingemanse, Jasper ; Delahaye, Stephane...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339695/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
1-14